These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43 related articles for article (PubMed ID: 7939751)
1. Global advances in prostate cancer diagnosis and therapy. Walia G; Sun Y; Soule HR Asian J Androl; 2013 May; 15(3):299-300. PubMed ID: 23603920 [No Abstract] [Full Text] [Related]
2. Capromab pendetide. A review of its use as an imaging agent in prostate cancer. Lamb HM; Faulds D Drugs Aging; 1998 Apr; 12(4):293-304. PubMed ID: 9571393 [TBL] [Abstract][Full Text] [Related]
3. Synergistic value of single-photon emission computed tomography/computed tomography fusion to radioimmunoscintigraphic imaging of prostate cancer. Sodee DB; Sodee AE; Bakale G Semin Nucl Med; 2007 Jan; 37(1):17-28. PubMed ID: 17161036 [TBL] [Abstract][Full Text] [Related]
4. Targeting tomoregulin for radioimmunotherapy of prostate cancer. Zhao XY; Schneider D; Biroc SL; Parry R; Alicke B; Toy P; Xuan JA; Sakamoto C; Wada K; Schulze M; Müller-Tiemann B; Parry G; Dinter H Cancer Res; 2005 Apr; 65(7):2846-53. PubMed ID: 15805286 [TBL] [Abstract][Full Text] [Related]
6. Current status of monoclonal antibodies for imaging and therapy of prostate cancer. Bander NH Semin Oncol; 1994 Oct; 21(5):607-12. PubMed ID: 7939751 [TBL] [Abstract][Full Text] [Related]
9. Targeted alpha-therapy for control of micrometastatic prostate cancer. Li Y; Russell PJ; Allen BJ Expert Rev Anticancer Ther; 2004 Jun; 4(3):459-68. PubMed ID: 15161444 [TBL] [Abstract][Full Text] [Related]